US Stock MarketDetailed Quotes

PTIX Protagenic Therapeutics

Watchlist
  • 0.3876
  • -0.0304-7.27%
Close Apr 4 16:00 ET
  • 0.3050
  • -0.0826-21.31%
Post 20:01 ET
2.92MMarket Cap-0.34P/E (TTM)

Protagenic Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-13.84%-4.22M
28.37%-819.79K
71.69%-185.66K
-1.31%-1.55M
-346.22%-1.66M
-85.76%-3.7M
-532.51%-1.14M
-22.52%-655.77K
-80.83%-1.53M
13.64%-371.83K
Net income from continuing operations
-10.50%-5.53M
7.30%-1.55M
54.12%-640.79K
-32.82%-1.61M
-140.12%-1.72M
-40.64%-5M
-178.73%-1.68M
-50.94%-1.4M
-81.42%-1.21M
47.28%-718.1K
Operating gains losses
-108.21%-51.73K
--0
--0
-143.33%-51.53K
-104.47%-198
1,268.74%630.32K
7,876.31%483.76K
96.66%23.18K
411.69%118.95K
-10.57%4.43K
Depreciation and amortization
78.21%50.29K
-52.77%12.57K
785.98%12.57K
13,714.29%12.57K
13,868.89%12.57K
93,960.00%28.22K
88,626.67%26.62K
--1.42K
--91
--90
Other non cash items
-193.75%-80.41K
----
----
----
----
-22.59%85.77K
22.72%31.24K
-82.50%4.45K
-24.30%25.18K
-6.49%24.9K
Change In working capital
508.65%467.54K
415.08%556.35K
-64.75%192.15K
72.86%-171.83K
-172.69%-109.13K
-121.18%-114.41K
-192.84%-176.58K
294.56%545.11K
-39.94%-633.07K
-77.40%150.13K
-Change in prepaid assets
214.40%99.63K
907.29%322.51K
-89.96%77.39K
53.49%-400.3K
133.06%100.03K
-113.79%-87.09K
-189.48%-39.95K
1,626.13%770.6K
-545.61%-860.65K
-93.65%42.92K
-Change in payables and accrued expense
1,446.40%367.92K
271.16%233.85K
150.89%114.76K
0.39%228.46K
-295.09%-209.16K
70.17%-27.33K
-193.86%-136.63K
-341.14%-225.49K
171.32%227.58K
1,026.72%107.21K
Cash from discontinued investing activities
Operating cash flow
-13.84%-4.22M
28.37%-819.79K
71.69%-185.66K
-1.31%-1.55M
-346.22%-1.66M
-85.76%-3.7M
-532.51%-1.14M
-22.52%-655.77K
-80.83%-1.53M
13.64%-371.83K
Investing cash flow
Cash flow from continuing investing activities
-41.31%2.8M
0
0
-0.75%1.6M
308.21%1.2M
199.03%4.78M
1,308.25%2.28M
65.22%590.72K
128.03%1.61M
-20.52%294.67K
Net PPE purchase and sale
--0
--0
----
----
----
-8,197.78%-149.78K
-5,106.04%-93.97K
----
----
----
Net investment purchase and sale
-43.09%2.8M
--0
--0
-0.75%1.6M
308.21%1.2M
208.06%4.93M
1,350.16%2.37M
80.83%646.53K
128.03%1.61M
-20.52%294.67K
Cash from discontinued investing activities
Investing cash flow
-41.31%2.8M
--0
--0
-0.75%1.6M
308.21%1.2M
199.03%4.78M
1,308.25%2.28M
65.22%590.72K
128.03%1.61M
-20.52%294.67K
Financing cash flow
Cash flow from continuing financing activities
1.96M
1.6M
316.96K
0
0
0
Net common stock issuance
--1.96M
--1.6M
--316.96K
----
----
--0
--0
--0
----
----
Cash from discontinued financing activities
Financing cash flow
--1.96M
--1.6M
--316.96K
----
----
--0
--0
--0
----
----
Net cash flow
Beginning cash position
498.49%1.29M
588.57%1.06M
321.35%924.6K
500.60%831.78K
498.49%1.29M
-60.24%215.19K
-3.15%153.33K
-35.21%219.44K
-71.28%138.49K
-60.24%215.19K
Current changes in cash
-48.69%549.91K
-31.00%782.27K
301.86%131.3K
15.42%92.65K
-491.34%-456.31K
370.06%1.07M
6,013.62%1.13M
63.40%-65.04K
157.27%80.27K
-29.03%-77.17K
Effect of exchange rate changes
-33.17%667
-56.63%399
91.60%-89
-75.11%167
-59.31%190
-98.59%998
-98.79%920
59.83%-1.06K
120.06%671
-42.06%467
End cash Position
42.75%1.84M
42.75%1.84M
588.57%1.06M
321.35%924.6K
500.60%831.78K
498.49%1.29M
498.49%1.29M
-3.15%153.33K
-35.21%219.44K
-71.28%138.49K
Free cash flow
-9.42%-4.22M
33.80%-819.79K
73.91%-185.66K
-1.31%-1.55M
-346.22%-1.66M
-93.10%-3.85M
-577.68%-1.24M
-32.95%-711.57K
-80.83%-1.53M
13.64%-371.83K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -13.84%-4.22M28.37%-819.79K71.69%-185.66K-1.31%-1.55M-346.22%-1.66M-85.76%-3.7M-532.51%-1.14M-22.52%-655.77K-80.83%-1.53M13.64%-371.83K
Net income from continuing operations -10.50%-5.53M7.30%-1.55M54.12%-640.79K-32.82%-1.61M-140.12%-1.72M-40.64%-5M-178.73%-1.68M-50.94%-1.4M-81.42%-1.21M47.28%-718.1K
Operating gains losses -108.21%-51.73K--0--0-143.33%-51.53K-104.47%-1981,268.74%630.32K7,876.31%483.76K96.66%23.18K411.69%118.95K-10.57%4.43K
Depreciation and amortization 78.21%50.29K-52.77%12.57K785.98%12.57K13,714.29%12.57K13,868.89%12.57K93,960.00%28.22K88,626.67%26.62K--1.42K--91--90
Other non cash items -193.75%-80.41K-----------------22.59%85.77K22.72%31.24K-82.50%4.45K-24.30%25.18K-6.49%24.9K
Change In working capital 508.65%467.54K415.08%556.35K-64.75%192.15K72.86%-171.83K-172.69%-109.13K-121.18%-114.41K-192.84%-176.58K294.56%545.11K-39.94%-633.07K-77.40%150.13K
-Change in prepaid assets 214.40%99.63K907.29%322.51K-89.96%77.39K53.49%-400.3K133.06%100.03K-113.79%-87.09K-189.48%-39.95K1,626.13%770.6K-545.61%-860.65K-93.65%42.92K
-Change in payables and accrued expense 1,446.40%367.92K271.16%233.85K150.89%114.76K0.39%228.46K-295.09%-209.16K70.17%-27.33K-193.86%-136.63K-341.14%-225.49K171.32%227.58K1,026.72%107.21K
Cash from discontinued investing activities
Operating cash flow -13.84%-4.22M28.37%-819.79K71.69%-185.66K-1.31%-1.55M-346.22%-1.66M-85.76%-3.7M-532.51%-1.14M-22.52%-655.77K-80.83%-1.53M13.64%-371.83K
Investing cash flow
Cash flow from continuing investing activities -41.31%2.8M00-0.75%1.6M308.21%1.2M199.03%4.78M1,308.25%2.28M65.22%590.72K128.03%1.61M-20.52%294.67K
Net PPE purchase and sale --0--0-------------8,197.78%-149.78K-5,106.04%-93.97K------------
Net investment purchase and sale -43.09%2.8M--0--0-0.75%1.6M308.21%1.2M208.06%4.93M1,350.16%2.37M80.83%646.53K128.03%1.61M-20.52%294.67K
Cash from discontinued investing activities
Investing cash flow -41.31%2.8M--0--0-0.75%1.6M308.21%1.2M199.03%4.78M1,308.25%2.28M65.22%590.72K128.03%1.61M-20.52%294.67K
Financing cash flow
Cash flow from continuing financing activities 1.96M1.6M316.96K000
Net common stock issuance --1.96M--1.6M--316.96K----------0--0--0--------
Cash from discontinued financing activities
Financing cash flow --1.96M--1.6M--316.96K----------0--0--0--------
Net cash flow
Beginning cash position 498.49%1.29M588.57%1.06M321.35%924.6K500.60%831.78K498.49%1.29M-60.24%215.19K-3.15%153.33K-35.21%219.44K-71.28%138.49K-60.24%215.19K
Current changes in cash -48.69%549.91K-31.00%782.27K301.86%131.3K15.42%92.65K-491.34%-456.31K370.06%1.07M6,013.62%1.13M63.40%-65.04K157.27%80.27K-29.03%-77.17K
Effect of exchange rate changes -33.17%667-56.63%39991.60%-89-75.11%167-59.31%190-98.59%998-98.79%92059.83%-1.06K120.06%671-42.06%467
End cash Position 42.75%1.84M42.75%1.84M588.57%1.06M321.35%924.6K500.60%831.78K498.49%1.29M498.49%1.29M-3.15%153.33K-35.21%219.44K-71.28%138.49K
Free cash flow -9.42%-4.22M33.80%-819.79K73.91%-185.66K-1.31%-1.55M-346.22%-1.66M-93.10%-3.85M-577.68%-1.24M-32.95%-711.57K-80.83%-1.53M13.64%-371.83K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More